Hilltop Holdings Inc. Paratek Pharmaceuticals, Inc. Transaction History

Hilltop Holdings Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$5.36 - $7.24 $112,292 - $151,678	-20,950 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$4.8 - $11.6 $56,880 - $137,460	-11,850 Reduced 36.13%	20,950 $107,000
Q3 2018 Nov 14, 2018	SELL	$9.05 - $10.95 $13,575 - $16,425	-1,500 Reduced 4.37%	32,800 $318,000
Q2 2018 Aug 14, 2018	SELL	$10.2 - $13.9 $31,619 - $43,090	-3,100 Reduced 8.29%	34,300 $350,000
Q1 2018 May 15, 2018	BUY	$12.65 - $18.85 $473,110 - $704,990	37,400 New	37,400 $486,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Hilltop Holdings Inc., based on Form 13F filings with the SEC.

Stay updated on Hilltop Holdings Inc. with notifications on news.